PARIS--(BUSINESS WIRE)--BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced that its 2008 Annual Report, in its capacity as Reference Document, was registered with the French Market Authorities on Tuesday, April 7, 2009. It is available free of charge to the public upon request as per current legal regulations at BioAlliance Pharma’s headquarters - 49 Boulevard du Général Martial Valin, 75015 Paris - and may be consulted at the http://www.bioalliancepharma.com website (under Investors / Publications).
